Read the full story: #thesiliconreview #FDA #VeraTherapeutics #Trutakna #IgAN #KidneyDisease #Biotech #Pharmaceuticals #HealthcareInnovation To view or add a comment, sign in 2,720 followers
GLP-1 receptor agonists caused dose-dependent thyroid C-cell tumors in rodent studies
Write it on an index card, print it out, or save it on your phone
One of the rarer side effects of semaglutide is related to gallbladder health, specifically gallstones hardened pieces of bile that develop over time
The adolescent Olumiant opportunity in alopecia areata, and its broader autoimmune use, adds detail that is not fully captured in a story mostly centered on cardiometabolic and neurodegenerative drugs, and highlights additional diversity in Lilly's portfolio relative to peers such as Novo Nordisk and Merck.
When combined with L-Carnitine, a nutrient that transports stored fat into cells to be burned for energy, patients gain both appetite control and enhanced metabolic support